Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Doerflinger

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
The FEBS Journal|September 7, 2020
Circulating BiP/Grp78 is a novel prognostic marker for sepsis-mediated immune cell deathMarcel Doerflinger, Boris Reljic, Joseph Menassa, et al.
Viruses|October 26, 2024
Current State of Therapeutics for HTLV-1Tiana T Wang, Ashley Hirons, Marcel Doerflinger, et al.
Clinical & Translational Immunology|January 13, 2021
Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myelomaMarcel Doerflinger, Alexandra L Garnham, Saskia Freytag, et al.
Plos Neglected Tropical Diseases|June 29, 2023
A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strainStephen Muhi, Joshua Osowicki, Daniel O'Brien, et al.
Clinical & Translational Immunology|August 6, 2025
Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemiaLewis J Williams, Connie Sn Li-Wai-Suen, Alex L Garnham, et al.
Cell Death & Disease|January 29, 2024
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivoStefanie M Bader, James P Cooney, Reet Bhandari, et al.
Wellcome Open Research|October 10, 2024
A human model of Buruli ulcer: Provisional protocol for a <i>Mycobacterium ulcerans</i> controlled human infection studyStephen Muhi, Julia L Marshall, Daniel P O'Brien, et al.
Cell Death and Differentiation|February 27, 2025
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signallingStefanie M Bader, Lena Scherer, Jan Schaefer, et al.
Nature Immunology|October 6, 2020
TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsisChristina Nedeva, Joseph Menassa, Mubing Duan, et al.
Cell Death and Differentiation|April 15, 2017
DR5 and caspase-8 are dispensable in ER stress-induced apoptosisJason A Glab, Marcel Doerflinger, Christina Nedeva, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
The FEBS Journal|September 7, 2020
Circulating BiP/Grp78 is a novel prognostic marker for sepsis-mediated immune cell deathMarcel Doerflinger, Boris Reljic, Joseph Menassa, et al.
Viruses|October 26, 2024
Current State of Therapeutics for HTLV-1Tiana T Wang, Ashley Hirons, Marcel Doerflinger, et al.
Clinical & Translational Immunology|January 13, 2021
Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myelomaMarcel Doerflinger, Alexandra L Garnham, Saskia Freytag, et al.
Plos Neglected Tropical Diseases|June 29, 2023
A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strainStephen Muhi, Joshua Osowicki, Daniel O'Brien, et al.
Clinical & Translational Immunology|August 6, 2025
Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemiaLewis J Williams, Connie Sn Li-Wai-Suen, Alex L Garnham, et al.
Cell Death & Disease|January 29, 2024
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivoStefanie M Bader, James P Cooney, Reet Bhandari, et al.
Wellcome Open Research|October 10, 2024
A human model of Buruli ulcer: Provisional protocol for a <i>Mycobacterium ulcerans</i> controlled human infection studyStephen Muhi, Julia L Marshall, Daniel P O'Brien, et al.
Cell Death and Differentiation|February 27, 2025
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signallingStefanie M Bader, Lena Scherer, Jan Schaefer, et al.
Nature Immunology|October 6, 2020
TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsisChristina Nedeva, Joseph Menassa, Mubing Duan, et al.
Cell Death and Differentiation|April 15, 2017
DR5 and caspase-8 are dispensable in ER stress-induced apoptosisJason A Glab, Marcel Doerflinger, Christina Nedeva, et al.
Pageof 5